Fort Collins, CO—Geocann and Atrium Innovations have launched cannabidiol (CBD) soft gel formulations using the VESIsorb drug delivery system, according to a press release. These products will be marketed under Pure Encapsulations, Douglas Laboratories, and Genestra Brands.
VESIsorb is a naturally self-assembling colloidal droplet delivery system that can improve the bioavailability of poorly absorbed natural ingredients, such as cannabinoids and terpenes, the release explains. This technology has been shown to be effective in a variety of studies and meta-analyses, conducted since 2005.
Dr. Barry Ritz, chief science officer at Atrium, said in the release: “Natural products utilizing VESIsorb have historically set the benchmark for delivering superior absorption and blood plasma levels that allow the body to use more of the active ingredients. This provides confidence that health conscious consumers will receive the maximum benefits from key cannabinoids and terpenes, like cannabidiol and beta-caryophyllene, found in our products.”
Jesse Lopez, CEO and founder of Geocann, said in the release: “Atrium Innovations has an iconic reputation built on a foundation of diligent scientific research and technologically advanced product formulations. As the industrial hemp market continues to flourish, these product launches provide exceptional credibility to the therapeutic benefits of cannabinoids formulated with VESIsorb.”